Camzyos (mavacamten) - BMS
Mavacamten for Obstructive HCM in Malignancy With Life-Threatening Symptoms. (PubMed, JACC Case Rep) - Oct 4, 2026 - "Multidisciplinary decision-making is paramount when considering novel therapies in complex cardio-oncology patients." 
Journal • Cardiomyopathy • Cardiovascular • Critical care • Gastrointestinal Neuroendocrine Tumor • Hepatology • Hypertrophic Cardiomyopathy • Liver Failure • Neuroendocrine Tumor • Obstructive Hypertrophic Cardiomyopathy • Oncology • Pancreatic Cancer • Respiratory Diseases • Solid Tumor
http://www.ncbi.nlm.nih.gov/pubmed/42828525
 
Ahmed Elshobaky; Alexander R Lyon; Alexandra Pons Riverola; Antonis Pantazis; Charlotte Fribbens; María Clara Llamedo; Muhummad Sohaib Nazir; Rajdeep Khattar; Richard Trimlett; Vijay Maharajan
 
Oct 4, 2026
 
Prev Next